The Association of Clinical Outcomes with Posttreatment Changes in the Relative Eosinophil Counts and Neutrophil-to-Eosinophil Ratio in Patients with Advanced Urothelial Carcinoma Treated with Pembrolizumab.
Nobuki FurubayashiAkinori MinatoTakahito NegishiNaotaka SakamotoYoohyun SongYoshifumi HoriToshihisa TomodaShingo TamuraKentaro KuroiwaNarihito SekiNaohiro FujimotoMotonobu NakamuraPublished in: Cancer management and research (2021)
An increased REC and decreased NER after pembrolizumab may be significant early predictive markers of improved clinical outcomes in patients with advanced UC receiving pembrolizumab.